SynthesisWorld journal of surgical oncology2024

Survival outcomes in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy: a meta-analysis.

Lin-Yu Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.